Monarch Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Sell
119,322
-1,237
-1% -$145K 3.53% 3
2026
Q1
$14.6M Sell
120,559
-2,307
-2% -$266K 3.57% 4
2025
Q4
$13M Sell
122,866
-476
-0.4% -$44.7K 3.2% 4
2025
Q3
$10.4M Buy
123,342
+1,462
+1% +$120K 2.56% 9
2025
Q2
$9.72M Buy
121,880
+2,667
+2% +$212K 2.61% 9
2025
Q1
$10.8M Buy
119,213
+2,304
+2% +$215K 2.99% 7
2024
Q4
$11.7M Buy
116,909
+597
+0.5% +$61.5K 3.2% 5
2024
Q3
$13.3M Buy
116,312
+418
+0.4% +$49.7K 3.57% 4
2024
Q2
$14.4M Sell
115,894
-2,141
-2% -$276K 4.24% 2
2024
Q1
$15.6M Sell
118,035
-658
-0.6% -$81.1K 4.41% 2
2023
Q4
$13M Sell
118,693
-455
-0.4% -$47.2K 3.94% 2
2023
Q3
$12.3M Sell
119,148
-29
-0% -$3.13K 3.96% 2
2023
Q2
$13.8M Sell
119,177
-1,290
-1% -$146K 4.19% 2
2023
Q1
$12.9M Sell
120,467
-6,250
-5% -$675K 3.95% 2
2022
Q4
$14.1M Sell
126,717
-5,051
-4% -$516K 4.33% 1
2022
Q3
$11.4M Sell
131,768
-2,663
-2% -$238K 3.72% 3
2022
Q2
$12.3M Sell
134,431
-5,286
-4% -$469K 3.65% 2
2022
Q1
$11.5M Buy
139,717
+886
+0.6% +$69.9K 3.03% 5
2021
Q4
$10.6M Sell
138,831
-964
-0.7% -$76.8K 2.73% 7
2021
Q3
$10.5M Buy
139,795
+1,029
+0.7% +$78.3K 2.92% 6
2021
Q2
$10.8M Sell
138,766
-6,639
-5% -$494K 3.08% 6
2021
Q1
$10.7M Sell
145,405
-893
-0.6% -$65.9K 3.17% 4
2020
Q4
$11.4M Sell
146,298
-858
-0.6% -$65.6K 3.59% 2
2020
Q3
$11.6M Sell
147,156
-254
-0.2% -$19.9K 4.05% 2
2020
Q2
$10.9M Buy
147,410
+921
+0.6% +$69.3K 3.97% 2
2020
Q1
$10.8M Buy
146,489
+1,863
+1% +$146K 4.39% 1
2019
Q4
$12.6M Sell
144,626
-1,632
-1% -$134K 4.1% 1
2019
Q3
$11.7M Sell
146,258
-2,951
-2% -$237K 4.11% 1
2019
Q2
$11.9M Sell
149,209
-904
-0.6% -$69.2K 4.26% 1
2019
Q1
$11.9M Sell
150,113
-1,468
-1% -$110K 4.32% 1
2018
Q4
$11.1M Sell
151,581
-1,011
-0.7% -$71.4K 4.47% 1
2018
Q3
$10.3M Sell
152,592
-5,663
-4% -$361K 3.74% 1
2018
Q2
$9.17M Sell
158,255
-4,883
-3% -$275K 3.51% 2
2018
Q1
$8.48M Buy
163,138
+5,211
+3% +$281K 3.26% 3
2017
Q4
$8.48M Sell
157,927
-3,469
-2% -$192K 3.15% 6
2017
Q3
$9.86M Sell
161,396
-1,123
-0.7% -$68.1K 3.68% 2
2017
Q2
$9.94M Sell
162,519
-28,524
-15% -$1.74M 3.76% 1
2017
Q1
$11.6M Buy
191,043
+316
+0.2% +$19.2K 4.24% 1
2016
Q4
$10.7M Sell
190,727
-1,643
-0.9% -$96.2K 4% 1
2016
Q3
$11.5M Sell
192,370
-21
-0% -$1.23K 4.34% 1
2016
Q2
$10.6M Sell
192,391
-201
-0.1% -$10.7K 3.94% 1
2016
Q1
$9.72M Buy
192,592
+3,851
+2% +$189K 3.5% 2
2015
Q4
$9.51M Sell
188,741
-1,048
-0.6% -$52.8K 3.65% 2
2015
Q3
$8.94M Sell
189,789
-622
-0.3% -$33K 3.64% 2
2015
Q2
$10.3M Sell
190,411
-1,004
-0.5% -$56.3K 3.95% 2
2015
Q1
$10.5M Sell
191,415
-546
-0.3% -$30.9K 3.97% 2
2014
Q4
$10.4M Buy
191,961
+200
+0.1% +$11.1K 3.94% 1
2014
Q3
$10.8M Sell
191,761
-4,024
-2% -$226K 4.33% 1
2014
Q2
$10.8M Sell
195,785
-2,097
-1% -$114K 4.17% 1
2014
Q1
$10.7M Sell
197,882
-2,903
-1% -$150K 4.24% 1
2013
Q4
$9.59M Sell
200,785
-2,374
-1% -$109K 3.76% 2
2013
Q3
$9.23M Buy
203,159
+474
+0.2% +$21.6K 3.87% 2
2013
Q2
$8.98M Buy
+202,685
New +$9.05M 3.87% 1

Other funds holding MRK

Monarch Capital Management's MRK Position: Q2 2026 in Review

Monarch Capital Management reduced its Merck (MRK) stake by 1% in Q2 2026, selling an estimated $145K and leaving 119,322 shares worth $15.4M. The position accounts for 3.53% of the portfolio, ranked #3.

Monarch Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.6M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Monarch Capital Management held 119,322 shares of Merck worth $15.4M as of Q2 2026.
  • Monarch Capital Management sold 1,237 Merck shares in Q2 2026, an estimated $145K.
  • Merck made up 3.53% of Monarch Capital Management's portfolio in Q2 2026, its #3 holding.
  • Monarch Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Monarch Capital Management's Merck position peaked at $15.6M in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.